Stay updated on Her2 Therapy & Pembrolizumab in Neoadjuvant Clinical Trial
Sign up to get notified when there's something new on the Her2 Therapy & Pembrolizumab in Neoadjuvant Clinical Trial page.

Latest updates to the Her2 Therapy & Pembrolizumab in Neoadjuvant Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page revision indicator was updated from v3.6.5 to v3.6.6, reflecting a small internal update to the page. No substantive changes to study content or user-facing details are indicated.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe page now shows Revision: v3.6.5, replacing the previous revision tag; this indicates a small backend update to the page without changes to the study details.SummaryDifference0.0%

- Check48 days agoChange DetectedUpdated the page revision from v3.6.3 to v3.6.4 to reflect a maintenance update. This change represents a metadata/version bump and does not affect the study content or user-facing features.SummaryDifference0.0%

- Check62 days agoChange DetectedThe study record shows new timestamps reflecting recent maintenance: last update posted on 2026-07-08 and last update submitted on 2026-06-12, along with a June 2026 entry. This indicates routine record upkeep rather than changes to the study details.SummaryDifference0.2%

- Check77 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.3 to reflect a newer page build. This change does not alter visible content, study details, or user-facing features.SummaryDifference0.0%

- Check91 days agoChange DetectedAdded a recruitment status note indicating enrollment is closed. Added/standardized navigation and help-content sections (How to Read a Study Record, Common Questions, How to Join a Study, Intervention/Treatment) and removed the older 'Intervention / Treatment' label to align with a site-wide formatting update.SummaryDifference0.4%

Stay in the know with updates to Her2 Therapy & Pembrolizumab in Neoadjuvant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Her2 Therapy & Pembrolizumab in Neoadjuvant Clinical Trial page.